Sector revisions Moderna, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 20/07/2026 BST			After hours 01:00:00
59.49 ^USD	-3.77%		61.48	+3.35%

07-20	Goldman Sachs Adjusts Moderna Price Target to $67 From $49, Maintains Neutral Rating	MT
07-16	Moderna advances its cancer therapy assessment, but the stock slides

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
MODERNA, INC.		19
REGENERON PHARMACEUTICALS, INC.		26
UCB		19
SAMSUNG BIOLOGICS CO.,LTD.		24
CSL LIMITED		16
BIOGEN INC.		30
INCYTE CORPORATION		22
INNOVENT BIOLOGICS, INC.		25
SWEDISH ORPHAN BIOVITRUM AB		12
BRIDGEBIO PHARMA, INC.		21
AXSOME THERAPEUTICS, INC.		20
BIOMARIN PHARMACEUTICAL INC.		25
KRYSTAL BIOTECH, INC.		9
ALTEOGEN INC.		5
GRIFOLS, S.A.		12
TWIST BIOSCIENCE CORPORATION		10
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	-	1
GAN & LEE PHARMACEUTICALS.		2
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	1
3SBIO INC.		9
Average		15
Weighted average by Cap.		20